Agilent Technologies ne digital pathology firm Proscia ko **$240 million** cash mein acquisition ka announcement kiya hai. Is deal mein **$30 million** ka bonus bhi shaamil hai, jisse company ab AI-enabled diagnostics ki duniya mein apna kadam jama rahi hai.
Nayi Strategy: Hardware se Software ki taraf
Agilent Technologies ne AI-powered pathology software banane wali company Proscia ko $240 million cash deal mein acquire kar liya hai. Saath hi, $30 million ka performance-based bonus bhi rakha gaya hai agar targets meet hote hain toh. Yeh acquisition Agilent ke liye ek major shift hai.
Kya hai bada game plan?
Agilent ab tak sirf laboratory hardware ke liye jaani jati thi. Lekin ab, wo apni physical diagnostic tools ke saath Proscia ki digital image analysis technology ko jod kar ek integrated ecosystem banana chahti hai. In dono companies ki partnership 2022 se chal rahi thi, aur ab Agilent ne poora workflow hi apne control mein le liya hai.
Revenue ka Naya Source
Proscia ka software abhi hazaron labs mein use ho raha hai aur pichle saal unka revenue $18 million ke paar tha. Agilent ka focus ab 'Software-as-a-Service' (SaaS) model par hai, jisse unhein equipment sales ke mukable zyada stable aur recurring income mil sake.
Investors ke liye Risks?
Har badi acquisition ki tarah, yahan bhi execution ka risk hai. Ek hardware-based manufacturing company mein software team ko integrate karna kaafi complex kaam hota hai. Agar integration cost badhi ya process mein deri hui, toh company ke margins par pressure aa sakta hai. Saath hi, AI diagnostics market mein competition bahut tagda hai.
Yeh deal Agilent ke Fiscal Year 2027 ki shuruat tak complete hone ki umeed hai. Ab investors ki nazar management ki commentary aur integration ke timeline par tiki hui hai.